Please assess the completion status of the following clinical trial:

Trial Title: Growth Hormone in Poor Responders to IVF Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subject with prior poor response(s) to ovarian stimulation for IVF or ICSI. Poor response is defined as a history of producing fewer than four follicles ≥14 mm in diameter during previous COS cycles where FSH or HMG was used from cycle start at a daily dose of ≥450 IU~* Age ≤ 45 years~* Baseline blood labs, measured within previous month, show fasting blood glucose \<6.1 mmol/L and TSH ≤ 5.5 mU/L~* Early follicular phase (Day 2 or Day 3) serum FSH, evaluated in the preceding 6 months~* Subject willing and able to give informed consent~Exclusion Criteria:~* Concurrently enrolled in any other clinical trial~* Previous participation in this study~* Using GnRH agonist in COS protocol~* Any prior early follicular phase serum FSH level ≥12 IU/L~* Use of any of the following is contraindicated or inappropriate: GH, Cetrotide®, FSH, LH or hCG~* Used OCP within the prior month~* Pregnant or lactating~* Untreated hydrosalpinx~* Tobacco smoker~* Diabetic or otherwise at risk of gestational diabetes~* BMI \> 38 kg/m2~* Poorly controlled thyroid disease~* Known cancer or prior history of malignancies

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 44 Years
- Healthy Volunteers: f

Study Arms:
- No Growth Hormone Supplementation (Type: ACTIVE_COMPARATOR): None
- Luteal Growth Hormone Start (Type: EXPERIMENTAL): Growth hormone starting in the luteal phase of the previous menstrual cycle.
- Follicular Growth Hormone Start (Type: EXPERIMENTAL): Starting growth hormone during the follicular phase of the prior menstrual cycle.

Based on this trial design, predict the completion outcome and termination type (if applicable).